losartan and sildenafil citrate

losartan has been researched along with sildenafil citrate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Cao, G; Lombraña, A; Rivero, M; Toblli, JE	1
Cai, Z; Gu, M; Guo, J; Li, WJ; Wang, Z; Xu, M; Zheng, DC	1
Bergler-Czop, B; Brzezińska-Wcisło, L; Drobek, HH; Miziołek, B; Pietrauszka, K; Porwolik, M	1

Reviews

1 review(s) available for losartan and sildenafil citrate

Article	Year
What is the Best Way to Treat Patients with Raynaud's Phenomenon and a Tendency towards Hypotension? Acta dermatovenerologica Croatica : ADC, 2020, Volume: 28, Issue:3 Topics: Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypotension; Losartan; Nifedipine; Nitroglycerin; Raynaud Disease; Sildenafil Citrate; Smoking Cessation; Stress, Psychological; Vasodilator Agents	2020

Other Studies

2 other study(ies) available for losartan and sildenafil citrate

Article	Year
Functional and morphological improvement in erectile tissue of hypertensive rats by long-term combined therapy with phosphodiesterase type 5 inhibitor and losartan. The journal of sexual medicine, 2007, Volume: 4, Issue:5 Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hypertension; Impotence, Vasculogenic; Longitudinal Studies; Losartan; Male; Muscle, Smooth, Vascular; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Inbred SHR; Rats, Wistar; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents	2007
Losartan Preserves Erectile Function by Suppression of Apoptosis and Fibrosis of Corpus Cavernosum and Corporal Veno-Occlusive Dysfunction in Diabetic Rats. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Collagen; Cyclic GMP; Diabetes Mellitus, Experimental; Fibrosis; Losartan; Male; Muscle, Smooth; Nitrites; Penile Erection; Rats; Rats, Sprague-Dawley; Signal Transduction; Sildenafil Citrate; Smad Proteins; Transforming Growth Factor beta1	2017

Article

Year

Functional and morphological improvement in erectile tissue of hypertensive rats by long-term combined therapy with phosphodiesterase type 5 inhibitor and losartan.

The journal of sexual medicine, 2007, Volume: 4, Issue:5

Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hypertension; Impotence, Vasculogenic; Longitudinal Studies; Losartan; Male; Muscle, Smooth, Vascular; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Inbred SHR; Rats, Wistar; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents

2007

Losartan Preserves Erectile Function by Suppression of Apoptosis and Fibrosis of Corpus Cavernosum and Corporal Veno-Occlusive Dysfunction in Diabetic Rats.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:1

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Collagen; Cyclic GMP; Diabetes Mellitus, Experimental; Fibrosis; Losartan; Male; Muscle, Smooth; Nitrites; Penile Erection; Rats; Rats, Sprague-Dawley; Signal Transduction; Sildenafil Citrate; Smad Proteins; Transforming Growth Factor beta1

2017